» Authors » Urszula Daniluk

Urszula Daniluk

Explore the profile of Urszula Daniluk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 236
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Swidnicka-Siergiejko A, Daniluk J, Miniewska K, Daniluk U, Guzinska-Ustymowicz K, Pryczynicz A, et al.
Cells . 2025 Mar; 14(5). PMID: 40072088
An association between gut microbiota and the development of pancreatic ductal adenocarcinoma (PDAC) has been previously described. To better understand the bacterial microbiota changes accompanying PDAC promotion and progression stimulated...
2.
Kucharska M, Zdanowicz K, Daniluk T, Bucki R, Lebensztejn D, Daniluk U
Med Sci Monit . 2023 Sep; 29:e941195. PMID: 37658600
BACKGROUND In recent years, an increasing prevalence of Helicobacter pylori resistance to antibiotics has been observed. The aim of this study was to assess antibiotic resistance of Helicobacter pylori in...
3.
Daniluk U, Krawiec P, Pac-Kozuchowska E, Dembinski L, Bukowski J, Banaszkiewicz A, et al.
J Clin Med . 2023 Jul; 12(13). PMID: 37445210
The coexistence of inflammatory bowel disease (IBD) with pancreatic pathology is rare in children. A retrospective analysis of data from 1538 children diagnosed with IBD in 2014-2021 was conducted to...
4.
Zdanowicz K, Daniluk J, Lebensztejn D, Daniluk U
Int J Mol Sci . 2022 Nov; 23(21). PMID: 36362164
The incidence of gallstone disease has increased in recent years. The pathogenesis of cholelithiasis is not fully understood. The occurrence of the disease is influenced by both genetic and environmental...
5.
Owsianko N, Romanczuk-Osenka N, Szczerbakow M, Pikora K, Sowa K, Daniluk U, et al.
Med Sci Monit . 2022 Nov; 28:e938243. PMID: 36316965
BACKGROUND The COVID-19 pandemic affected many people worldwide, including those with chronic diseases. Our objective was to analyze its influence on medical care and the course of inflammatory bowel disease...
6.
Zdanowicz K, Bobrus-Chcociej A, Pogodzinska K, Blachnio-Zabielska A, Zelazowska-Rutkowska B, Lebensztejn D, et al.
J Clin Med . 2022 Oct; 11(19). PMID: 36233480
(1) Background: Disturbances in the sphingolipid profile are observed in many diseases. There are currently no data available on the evaluation of sphingolipids and ceramides in cholelithiasis in children. The...
7.
Kwiatek-Sredzinska K, Kirylowska M, Uscinowicz M, Daniluk U, Lebensztejn D
Acta Paediatr . 2022 Aug; 111(11):2229-2234. PMID: 35960175
Aim: To evaluate the usefulness of routinely measured biochemical and complete blood count parameters as potential markers of the severity of paediatric acute pancreatitis (AP). Methods: The retrospective study included...
8.
Daniluk J, Daniluk U, Rogalski P, Swidnicka-Siergiejko A, Wasielica-Berger J, Kucharski R, et al.
Ann Agric Environ Med . 2022 Jun; 29(2):246-251. PMID: 35767758
Introduction And Objective: Epidemiological studies have demonstrated a strong association between cigarette smoking (CS) and chronic pancreatitis (CP); however, the exact mechanisms of this phenomenon remains unknown. The authors have...
9.
Czajkowska A, Guzinska-Ustymowicz K, Pryczynicz A, Lebensztejn D, Daniluk U
J Clin Med . 2022 May; 11(9). PMID: 35566780
Matrix Metaloproteinase-9 (MMP-9) and Tissue Inhibitor of Metaloproteinase-1 (TIMP-1), enzymes involved in tissue remodelling, have been previously reported to be overexpressed in the colonic mucosa of patients with Ulcerative colitis...
10.
Ryzko J, Zdanowicz K, Lebensztejn D, Daniluk U
Pediatr Rep . 2022 Jan; 14(1):26-31. PMID: 35076578
Extraintestinal manifestations (EIMs) are observed in 15-20% of patients with inflammatory bowel disease (IBD). One of the rare EIMs is myocarditis, the incidence of which is estimated at around 1%....